Expression of p63 in tooth germ, dentigerous cyst and ameloblastoma.
Cytodifferentiation
labeling index
odontogenic lesion
oncogenesis
Journal
Journal of oral and maxillofacial pathology : JOMFP
ISSN: 0973-029X
Titre abrégé: J Oral Maxillofac Pathol
Pays: India
ID NLM: 101227995
Informations de publication
Date de publication:
Historique:
entrez:
22
5
2019
pubmed:
22
5
2019
medline:
22
5
2019
Statut:
ppublish
Résumé
To assess the role of p63, a p53 homolog, in the cytodifferentiation (odontogenesis) and oncogenesis of odontogenic epithelium. The present study aimed to compare the expression pattern of p63 in the epithelium of tooth germ, dentigerous cyst (DC) and ameloblastoma (AB). Tissue specimens of thirty tooth germs, thirty ABs and thirty DCs were examined by immunohistochemistry for the expression of p63. Results: p63 labeling index (LI) was observed in descending order in epithelial cells of ABs, tooth germs and DCs. p63 LI was statistically nonsignificant among all the three groups. ABs revealed the highest p63 expression, but, surprisingly, tooth germs showed higher expression than DCs. p63 plays a role in the cytodifferentiation and proliferation of odontogenic epithelial cells irrespective of the tissue (normal developing or lesional tissue). This implies that p63 cannot be used as a diagnostic marker. However, our results indicate p63 overexpression as a mark of increased proliferation. Thus, it can be stipulated that p63 can be used as a prognostic marker in odontogenic lesions with more aggressive and invasive phenotype. Our results also suggest the differential function of p63 in both developing and lesional odontogenic tissues, which, however, depends on p63 isoform predominantly being expressed. Therefore, identification of p63-predominant isoform in a particular lesion is more important than the presence or absence of p63. Consequently, we suggest the performance of polymerase chain reaction analysis along with immunohistochemical evaluation in further studies.
Identifiants
pubmed: 31110415
doi: 10.4103/jomfp.JOMFP_125_18
pii: JOMFP-23-43
pmc: PMC6503805
doi:
Types de publication
Journal Article
Langues
eng
Pagination
43-48Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
Cancer Res. 1999 Sep 1;59(17):4165-9
pubmed: 10485447
Cell. 1999 Oct 15;99(2):143-53
pubmed: 10535733
J Invest Dermatol. 1999 Dec;113(6):1099-105
pubmed: 10594758
Biochim Biophys Acta. 2000 May 17;1470(3):M93-M100
pubmed: 10799748
Oral Oncol. 2001 Feb;37(2):193-8
pubmed: 11167148
Mod Pathol. 2002 Mar;15(3):331-41
pubmed: 11904346
J Med Genet. 2002 Jun;39(6):377-81
pubmed: 12070241
J Dent Res. 2002 Aug;81(8):525-30
pubmed: 12147741
Cancer Genet Cytogenet. 2002 Jul 1;136(1):31-7
pubmed: 12165448
Mol Cell Biol. 2002 Dec;22(24):8659-68
pubmed: 12446784
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Feb;95(2):213-21
pubmed: 12582363
J Oral Pathol Med. 2004 May;33(5):292-9
pubmed: 15078490
Histopathology. 2004 Jul;45(1):65-72
pubmed: 15228445
J Oral Pathol Med. 2005 Apr;34(4):220-6
pubmed: 15752257
Oral Oncol. 2008 Jan;44(1):50-60
pubmed: 17307020
Oral Oncol. 2008 Aug;44(8):805-11
pubmed: 18207448
Arch Pathol Lab Med. 2010 Feb;134(2):271-5
pubmed: 20121617
Saudi Med J. 2011 May;32(5):463-6
pubmed: 21556465
Biomed Res Int. 2013;2013:624176
pubmed: 24350278
Cell. 1989 Jun 30;57(7):1083-93
pubmed: 2525423
Nature. 1989 Dec 7;342(6250):705-8
pubmed: 2531845
J Oral Pathol Med. 1995 Oct;24(9):393-7
pubmed: 8537911
Cell. 1997 Aug 22;90(4):809-19
pubmed: 9288759
Nat Med. 1998 Jul;4(7):839-43
pubmed: 9662378
Mol Cell. 1998 Sep;2(3):305-16
pubmed: 9774969
Oral Oncol. 1998 Sep;34(5):408-12
pubmed: 9861350